BILLERICA, Mass.--(BUSINESS WIRE)--
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader
insulin pump technology with its Omnipod® Insulin Management System,
today announced that management will present at the 35th
Annual J.P. Morgan Healthcare Conference in San Francisco, California
on Monday, January 9th, 2017 at 3:30 p.m. Pacific Time.
To listen to a live audio webcast of the presentation, please visit http://investors.insulet.com/.
A replay of the webcast will also be available following the event.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD) is an innovative medical device
company dedicated to making the lives of people with diabetes easier.
Through its Omnipod Insulin Management System, Insulet seeks to expand
the use of insulin pump therapy among people with insulin-dependent
diabetes. The Omnipod is a revolutionary and easy-to-use tubeless
insulin pump that features just two parts and a fully-automated cannula
insertion. Insulet's Delivery Systems business also partners with global
pharmaceutical and biotechnology companies to tailor the Omnipod
technology platform for the delivery of subcutaneous drugs across
multiple therapeutic areas. Founded in 2000, Insulet Corporation is
based in Billerica, Massachusetts. For more information, please visit: http://www.myomnipod.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161220005662/en/
Investor Relations and Media Contact:
Vice President, Investor Relations and
Source: Insulet Corporation
News Provided by Acquire Media